1. Home
  2. CRSP vs LPL Comparison

CRSP vs LPL Comparison

Compare CRSP & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$50.24

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

HOLD

Current Price

$3.87

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
LPL
Founded
2013
1985
Country
Switzerland
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.2B
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
CRSP
LPL
Price
$50.24
$3.87
Analyst Decision
Buy
Hold
Analyst Count
20
1
Target Price
$71.95
N/A
AVG Volume (30 Days)
1.8M
776.2K
Earning Date
02-11-2026
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.31
Revenue
$38,337,000.00
$17,879,960,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,376.73
$0.81
P/E Ratio
N/A
$25.06
Revenue Growth
N/A
N/A
52 Week Low
$30.04
$2.43
52 Week High
$78.48
$5.67

Technical Indicators

Market Signals
Indicator
CRSP
LPL
Relative Strength Index (RSI) 40.76 33.12
Support Level $49.10 $3.81
Resistance Level $53.00 $4.46
Average True Range (ATR) 3.12 0.14
MACD -0.48 -0.05
Stochastic Oscillator 12.40 5.30

Price Performance

Historical Comparison
CRSP
LPL

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

Share on Social Networks: